Clinical trial

Celecoxib in Parkinson Disease as Adjuvant Therapy

NCT07246278

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-11-20

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2025-11-20Date precision: day

Registry last updated2025-12-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Parkinson Diseaseunresolved

Interventions

Levodopa CarbidopaDRUG

Celecoxib 200mgDRUG

Sponsors & collaborators

Tanta Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07246278 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.